This webinar focuses on ideas for educational outreach to promote the purposes and value of clinical research within organizations and communities, and considers what measures sponsors and sites can take to engage diverse patients in their clinical trials.
This webinar offers organizations valuable knowledge regarding how to create a process for internally monitoring the quality and safety of investigator-initiated trials. Templates, workflows, and other tools are shared so that learners may adapt the proposed program to their own institutional needs.
This webinar considers how sites are shifting away from sponsor-provided systems into technology that meets their business needs. As the options for technology solutions continue to grow, research sites must develop a true technology strategy and develop proficiencies in selecting, implementing, maintaining, and connecting their technology.
This webinar provides an overview of the mechanisms through which, in pandemic conditions, experimental COVID-19 therapies and diagnostics were made available to patients and providers before clinical trials had established whether those products were safe and effective. Also considered are how this state of affairs affected researchers’ ability to generate substantial evidence of product effectiveness through high-quality trials and the U.S. Food and Drug Administration’s deliberations over potential COVID-19 vaccines.
This second of two webinars on best practices in crafting standard operating procedures (SOPs) for clinical trials applies the concept of emotional quotient-based design thinking to appropriately draft SOPs that include all potential stakeholders. Also considered will be common blind spots within basic compliance mechanisms and the keys for drafting more adaptive SOPs to serve as reference tools and training materials for preparing your organization for new ways of conducting clinical trials.